Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (381-390 of 682) with videos related to

Pageof 69
Sort By:
Gynecologic Oncology|August 30, 2024
Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicityClare Meernik, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.
Neoplasia (New York, N.Y.)|September 14, 2024
Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancerPamela N Peters, Regina S Whitaker, Felicia Lim, et al.
The Journal of Pathology|March 3, 2025
Cellular origins of mucinous ovarian carcinomaNicola S Meagher, Martin Köbel, Anthony N Karnezis, et al.
Cancer Research|May 20, 2004
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancerMara H Rendi, Nanjoo Suh, William W Lamph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Frequency of germline and somatic BRCA1 mutations in ovarian cancerA Berchuck, K A Heron, M E Carney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancersAndrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
Cancer|December 26, 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisalC van Haaften-Day, Y Shen, F Xu, et al.
Cancer Research|March 25, 1992
Overexpression and mutation of p53 in endometrial carcinomaM F Kohler, A Berchuck, A M Davidoff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2017
Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future DirectionsSiddhartha P Kar, Andrew Berchuck, Simon A Gayther, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Development and Pilot Testing of a Mobile App Psychosocial Intervention for Psychological Distress in Individuals with GlaucomaHannah M Fisher, Natalie A Chou, Margaret Falkovic, et al.
Pageof 69

Showing results (381-390 of 682) with videos related to

Sort By:
Pageof 69
Gynecologic Oncology|August 30, 2024
Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicityClare Meernik, Oyomoare L Osazuwa-Peters, Lauren E Wilson, et al.
Neoplasia (New York, N.Y.)|September 14, 2024
Oncolytic adenovirus MEM-288 encoding membrane-stable CD40L and IFNβ induces an anti-tumor immune response in high grade serous ovarian cancerPamela N Peters, Regina S Whitaker, Felicia Lim, et al.
The Journal of Pathology|March 3, 2025
Cellular origins of mucinous ovarian carcinomaNicola S Meagher, Martin Köbel, Anthony N Karnezis, et al.
Cancer Research|May 20, 2004
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancerMara H Rendi, Nanjoo Suh, William W Lamph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Frequency of germline and somatic BRCA1 mutations in ovarian cancerA Berchuck, K A Heron, M E Carney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancersAndrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
Cancer|December 26, 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisalC van Haaften-Day, Y Shen, F Xu, et al.
Cancer Research|March 25, 1992
Overexpression and mutation of p53 in endometrial carcinomaM F Kohler, A Berchuck, A M Davidoff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 16, 2017
Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future DirectionsSiddhartha P Kar, Andrew Berchuck, Simon A Gayther, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Development and Pilot Testing of a Mobile App Psychosocial Intervention for Psychological Distress in Individuals with GlaucomaHannah M Fisher, Natalie A Chou, Margaret Falkovic, et al.
Pageof 69